Portal de Periódicos da CAPES

Bioavailability by design — Vitamin D3 liposomal delivery vehicles

2022; Elsevier BV; Volume: 43; Linguagem: Inglês

10.1016/j.nano.2022.102552

1549-9642

Paulina Dałek, Dominik Drabik, Halina Wołczańska, Aleksander Foryś, Małgorzata Jagas, Natalia Jędruchniewicz, Magdalena Przybyło, Wojciech Witkiewicz, Marek Langner,

Advancements in Transdermal Drug Delivery

Vitamin D3 deficiency has serious health consequences, as demonstrated by its effect on severity and recovery after COVID-19 infection. Because of high hydrophobicity, its absorption and subsequent redistribution throughout the body are inherently dependent on the accompanying lipids and/or proteins. The effective oral vitamin D3 formulation should ensure penetration of the mucus layer followed by internalization by competent cells. Isothermal titration calorimetry and computer simulations show that vitamin D3 molecules cannot leave the hydrophobic environment, indicating that their absorption is predominantly driven by the digestion of the delivery vehicle. In the clinical experiment, liposomal vitamin D3 was compared to the oily formulation. The results obtained show that liposomal vitamin D3 causes a rapid increase in the plasma concentration of calcidiol. No such effect was observed when the oily formulation was used. The effect was especially pronounced for people with severe vitamin D3 deficiency.